JRJ. Dennis Rupa

J. Dennis Rupa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J. Dennis Rupa has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Adriaan P. de Bruïne

    Research Institute of Growth and Development, Department of Pathology, University Hospital Maastricht, Maastricht, The Netherlands

    1 shared publication
  • Alfons G. H. Kessels

    Department of Clinical Epidemiology and Assessment Technology, University Hospital Maastricht, Maastricht, The Netherlands

    1 shared publication
  • Andrea J. Gerbers

    Research Institute of Growth and Development, Department of Pathology, University Hospital Maastricht, Maastricht, The Netherlands

    1 shared publication
  • Bert Schutte

    Research Institute of Growth and Development, Department of Molecular Cell Biology and Genetics, University of Maastricht, Maastricht, The Netherlands

    1 shared publication
  • Jan Willem Arends

    Department of Pathology, Deventer Hospital, Deventer, The Netherlands

    1 shared publication
  • Marius Nap

    Department of Pathology, Atrium Medical Centre, Heerlen, The Netherlands

    1 shared publication

Latest Publications

  • Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low‐turnover tumors with distinct clinical outcome

    by J. Dennis Rupa, Adriaan P. de Bruïne, Andrea J. Gerbers, Mathie P. G. Leers, Marius Nap, Alfons G. H. Kessels, Bert Schutte, Jan Willem Arends

    BACKGROUND: Dukes C colorectal carcinoma is treated with adjuvant chemotherapy. Adjuvant treatment is not standard for patients with Dukes B tumors, even though about 20% of patients within this tumor stage die of recurrent disease. The authors investigated whether a novel method of simultaneous detection of apoptosis and proliferation would improve the assessment of prognosis in colorectal carcinoma patients, with the ultimate goal of accurately identifying patients eligible for adjuvant therapy.METHODS: A multiparameter flow cytometric assay with heat pretreatment was performed on 278 paraffin‐embedded colorectal adenocarcinomas. After immunochemical isolation of tumor cells, apoptosis and proliferation were assessed simultaneously by immunostaining for the M30 antibody and by quantitative DNA analysis, respectively. Patients were followed for more than 10 years.RESULTS: The mean values of apoptosis (apoptotic fraction [AF], i.e., the percentage of M30‐positive cells) and proliferation (S‐phase fraction [SPF]) were 11.1% and 13.1%, respectively. The AF and SPF values were correlated positively (P = 0.01) and both increased with advancing tumor stage (P = 0.02). Combining AF and SPF, patients with tumors with a high turnover (i.e., both AF and SPF values were greater than the mean) had an overall survival rate of 13%, whereas patients with low‐turnover tumors (i.e., both AF and SPF values were less than the mean) had an overall survival rate of 89% (P < 0.001 by log rank test). Moreover, within Dukes B and C stages, patients with high‐turnover tumors had a poorer survival than patients with low‐turnover tumors (P < 0.001 for both stages).CONCLUSIONS: The simultaneous detection of apoptosis and proliferation in archival material allows separation of high and low‐turnover colorectal adenocarcinomas and improves the assessment of prognosis. This technique could be used to stratify patients for adjuvant chemotherapy. Cancer 2003;97:2404–11. © 2003 American Cancer Society.DOI 10.1002/cncr.11366